Division of Molecular Genetics and Epigenetics, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan.
J Hum Genet. 2013 Jul;58(7):402-9. doi: 10.1038/jhg.2013.51. Epub 2013 May 30.
Genomic imprinting is an epigenetic phenomenon that leads to parent-specific differential expression of a subset of genes. Most imprinted genes form clusters, or imprinting domains, and are regulated by imprinting control regions. As imprinted genes have an important role in growth and development, aberrant expression of imprinted genes due to genetic or epigenetic abnormalities is involved in the pathogenesis of human disorders, or imprinting disorders. Beckwith-Wiedemann syndrome (BWS) is a representative imprinting disorder characterized by macrosomia, macroglossia and abdominal wall defects, and exhibits a predisposition to tumorigenesis. The relevant imprinted chromosomal region in BWS is 11p15.5, which consists of two imprinting domains, IGF2/H19 and CDKN1C/KCNQ1OT1. BWS has five known causative epigenetic and genetic alterations: loss of methylation (LOM) at KvDMR1, gain of methylation (GOM) at H19DMR, paternal uniparental disomy, CDKN1C mutations and chromosomal rearrangements. Opposite methylation defects, GOM and LOM, at H19DMR are known to cause clinically opposite disorders: BWS and Silver-Russell syndrome, respectively. Interestingly, a recent study discovered that loss of function or gain of function of CDKN1C also causes clinically opposite disorders, BWS and IMAGe (intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies) syndrome, respectively. Furthermore, several clinical studies have suggested a relationship between assisted reproductive technology (ART) and the risk of imprinting disorders, along with the existence of trans-acting factors that regulate multiple imprinted differentially methylated regions. In this review, we describe the latest knowledge surrounding the imprinting mechanism of 11p15.5, in addition to epigenetic and genetic etiologies of BWS, associated childhood tumors, the effects of ART and multilocus hypomethylation disorders.
基因组印迹是一种表观遗传现象,导致一部分基因的亲源性特异性表达。大多数印迹基因形成簇或印迹域,并受印迹控制区的调控。由于印迹基因在生长和发育中起着重要作用,因此由于遗传或表观遗传异常导致印迹基因的异常表达与人类疾病或印迹疾病的发病机制有关。贝克威思-威德曼综合征(BWS)是一种代表性的印迹疾病,其特征为巨大儿、巨舌和腹壁缺陷,并表现出肿瘤发生的易感性。BWS 相关的印迹染色体区域位于 11p15.5,它由两个印迹域组成,IGF2/H19 和 CDKN1C/KCNQ1OT1。BWS 有五个已知的病因学表观遗传和遗传改变:KvDMR1 去甲基化(LOM)、H19DMR 获得甲基化(GOM)、父源单亲二体、CDKN1C 突变和染色体重排。H19DMR 相反的甲基化缺陷,GOM 和 LOM,已知分别导致临床上相反的疾病:BWS 和 Silver-Russell 综合征。有趣的是,最近的一项研究发现,CDKN1C 的功能丧失或获得功能也会导致临床上相反的疾病,分别是 BWS 和 IMAGe(宫内生长受限、干骺端发育不良、先天性肾上腺发育不全和生殖器异常)综合征。此外,几项临床研究表明,辅助生殖技术(ART)与印迹疾病的风险之间存在关联,以及存在调节多个印迹差异甲基化区域的转激活因子。在这篇综述中,我们描述了围绕 11p15.5 印迹机制的最新知识,以及 BWS 的表观遗传和遗传病因、相关儿童肿瘤、ART 的影响和多基因低甲基化疾病。